Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Mickey
Mickey is an MD/MPH candidate at Columbia University's Vagelos College of Physicians and Surgeons and the Mailman School of Public Health. He holds a BA in Biochemistry and English (Drake) and an MS in Narrative Medicine (Columbia).
Carla
Carla is an MD/PhD candidate in the Health Sciences and Technology program at Harvard-MIT. She earned her BS in Bioengineering from UPenn and her MS in Regenerative Medicine from the National University of Ireland.